electroCore (ECOR) announced that gammaCore Sapphire has been included in a long-term reimbursement policy launched by the National Institute for Health and Disability Insurance in Belgium. Effective October 1, 2025, the policy provides coverage for gammaCore Sapphire to treat patients with cluster headaches. This coverage is based on strong clinical evidence supporting the therapy’s efficacy and cost-effectiveness and ensures broader access for Belgian patients.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ECOR:
- electroCore announces Cuneo to depart from board, Errico to succeed as Chairman
- electroCore partners with iHeartRadio, former NY Jets linebacker Buttle
- Electrocore Expands Board with New Appointments
- electroCore appoints Elena Bonfiglioli to board of directors
- electroCore appoints Benning as SVP of Truvaga